Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation [Brief Reports]
Conclusions—
Dabigatran treatment within 24 hours of minor stroke is feasible. A larger randomized trial is required to confirm the safety and efficacy of this treatment approach.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT 01769703.
Source: Stroke - Category: Neurology Authors: Kate, M., Gioia, L., Buck, B., Sivakumar, L., Jeerakathil, T., Shuaib, A., Butcher, K. Tags: Anticoagulants Brief Reports Source Type: research
More News: Atrial Fibrillation | Clinical Trials | Health | Hemorrhagic Stroke | Ischemic Stroke | MRI Scan | Neurology | Pradaxa | Stroke